<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9622755</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">36330314</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9622755</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnhum.2022.943618</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>TABLE 1</table-label><table-caption>Patient demographic and disease information from ON and (TON-like) OGI studies reviewed in this paper. Studies are listed in increasing order of average onset duration in patient population at the time of data collection. Unless stated, all studies included patients without other apparent cause of vision loss and retro geniculate diseases. ON = optic neuritis; OGI = open globe injury.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>TABLE 1</label><caption><p>Patient demographic and disease information from ON and (TON-like) OGI studies reviewed in this paper. Studies are listed in increasing order of average onset duration in patient population at the time of data collection. Unless stated, all studies included patients without other apparent cause of vision loss and retro geniculate diseases. ON = optic neuritis; OGI = open globe injury.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Author, Year</td><td valign="top" align="center" rowspan="1" colspan="1">Number of patients</td><td valign="top" align="center" rowspan="1" colspan="1">Age (Range/Mean) (± SD)</td><td valign="top" align="left" rowspan="1" colspan="1">Stage &amp; type of disease; # of occurrences</td><td valign="top" align="left" rowspan="1" colspan="1">Mean time from onset at data collection</td></tr></thead><tbody><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>ON</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B23" ref-type="bibr">Shao et al., 2015</xref></td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">46.08 (± 7.91)</td><td valign="top" align="left" rowspan="1" colspan="1">ON</td><td valign="top" align="left" rowspan="1" colspan="1">5.3 days (± 3.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B13" ref-type="bibr">Huang et al., 2015</xref></td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">44.83 (± 10.71)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute ON</td><td valign="top" align="left" rowspan="1" colspan="1">5.4 days (± 2.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B36" ref-type="bibr">Yan et al., 2022</xref></td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">44.83 (± 10.71)</td><td valign="top" align="left" rowspan="1" colspan="1">ON</td><td valign="top" align="left" rowspan="1" colspan="1">5.4 days (± 2.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B35" ref-type="bibr">Wu et al., 2015</xref></td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">24–56 (median: 35)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute; clinically isolated ON</td><td valign="top" align="left" rowspan="1" colspan="1">50 days (± 25)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B1" ref-type="bibr">Backner et al., 2018</xref></td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">18 – 65</td><td valign="top" align="left" rowspan="1" colspan="1">Clinically isolated ON</td><td valign="top" align="left" rowspan="1" colspan="1">1–28 months (median: 3–4 months)</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>OGI</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B27" ref-type="bibr">Tan et al., 2016</xref></td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">44.6 (± 14.08)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute OGI</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 day (± 1.23)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B29" ref-type="bibr">Wang H. et al., 2017</xref></td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">44.17 (± 13.94)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute, <italic>unilateral</italic> OGI</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 day (± 1.23)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B14" ref-type="bibr">Huang et al., 2016</xref></td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">44.6 (± 14.08)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute OGI</td><td valign="top" align="left" rowspan="1" colspan="1">1.1 day (± 0.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B37" ref-type="bibr">Ye et al., 2018</xref></td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">43.05 (± 8.79)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute OGI</td><td valign="top" align="left" rowspan="1" colspan="1">6.6 days (± 3.4)</td></tr></tbody></table></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Patient demographic and disease information from ON and (TON-like) OGI studies reviewed in this paper. Studies are listed in increasing order of average onset duration in patient population at the time of data collection. Unless stated, all studies included patients without other apparent cause of vision loss and retro geniculate diseases. ON = optic neuritis; OGI = open globe injury.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left">Author, Year</td><td valign="top" align="center">Number of patients</td><td valign="top" align="center">Age (Range/Mean) (± SD)</td><td valign="top" align="left">Stage &amp; type of disease; # of occurrences</td><td valign="top" align="left">Mean time from onset at data collection</td></tr></thead><tbody><tr><td valign="top" align="left" colspan="5">ON</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">12</td><td valign="top" align="center">46.08 (± 7.91)</td><td valign="top" align="left">ON</td><td valign="top" align="left">5.3 days (± 3.2)</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">12</td><td valign="top" align="center">44.83 (± 10.71)</td><td valign="top" align="left">Acute ON</td><td valign="top" align="left">5.4 days (± 2.9)</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">21</td><td valign="top" align="center">44.83 (± 10.71)</td><td valign="top" align="left">ON</td><td valign="top" align="left">5.4 days (± 2.9)</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">15</td><td valign="top" align="center">24–56 (median: 35)</td><td valign="top" align="left">Acute; clinically isolated ON</td><td valign="top" align="left">50 days (± 25)</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">18</td><td valign="top" align="center">18 – 65</td><td valign="top" align="left">Clinically isolated ON</td><td valign="top" align="left">1–28 months (median: 3–4 months)</td></tr><tr><td valign="top" align="left" colspan="5">OGI</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">18</td><td valign="top" align="center">44.6 (± 14.08)</td><td valign="top" align="left">Acute OGI</td><td valign="top" align="left">1.0 day (± 1.23)</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">18</td><td valign="top" align="center">44.17 (± 13.94)</td><td valign="top" align="left">Acute, unilateral OGI</td><td valign="top" align="left">1.0 day (± 1.23)</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">18</td><td valign="top" align="center">44.6 (± 14.08)</td><td valign="top" align="left">Acute OGI</td><td valign="top" align="left">1.1 day (± 0.4)</td></tr><tr><td valign="top" align="left">???</td><td valign="top" align="center">18</td><td valign="top" align="center">43.05 (± 8.79)</td><td valign="top" align="left">Acute OGI</td><td valign="top" align="left">6.6 days (± 3.4)</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>